Hepatitis B virus DNA levels and outcomes in chronic hepatitis B
Open Access
- 27 April 2009
- journal article
- meeting report
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 49 (S5), S72-S84
- https://doi.org/10.1002/hep.22884
Abstract
Serum hepatitis B virus (HBV) DNA levels can fluctuate markedly during the course of chronic HBV infection. Both case-control and cohort studies have shown a significant, dose-response association between serum HBV DNA levels measured at the time of initial evaluation and the subsequent risk of cirrhosis. A similar direct relationship has been shown for the risk of hepatocellular carcinoma (HCC) in cross-sectional, case-control, and cohort studies. Interventional studies have shown a strong correlation between the indices of disease activity seen on liver biopsy and levels of serum HBV DNA. These studies have also shown that reduction in HBV DNA levels correlate strongly with improvements in liver histology. For patients with HCC, prognosis (including risk of death, metastasis, and recurrence following surgery) is worse with higher serum HBV DNA levels. The preponderance of the evidence in the published literature demonstrates that serum HBV DNA level is an important and independent risk factor for disease progression in chronic hepatitis B. The relative importance of serial HBV DNA measurements, the loss of hepatitis B e and surface antigens, as well as the emergence of HBV mutants in the progression of chronic hepatitis B, especially in young patients, is an important need for future research. (HEPATOLOGY 2009;49:S72–S84.)Keywords
This publication has 44 references indexed in Scilit:
- Viremia Profiles in Children With Chronic Hepatitis B Virus Infection and Spontaneous e Antigen SeroconversionGastroenterology, 2007
- Serum hepatitis B virus DNA as a predictor of the development of cirrhosis and hepatocellular carcinomaCurrent Hepatitis Reports, 2007
- Nationwide Hepatitis B Vaccination Program in Taiwan: Effectiveness in the 20 Years After It Was LaunchedEpidemiologic Reviews, 2006
- The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosisApoptosis, 2005
- Time-dependent events in natural history of occult hepatitis B virus infection: the importance of population-based long-term follow-up study with repeated measurementsJournal of Hepatology, 2005
- Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiologyHepatology, 2002
- Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow TransplantationAnnals of Internal Medicine, 2002
- Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon TherapyAnnals of Internal Medicine, 2000
- Epidemiological characteristics and risk factors of hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 1997
- Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in ChildrenNew England Journal of Medicine, 1997